Molecular Cancer · 2004 · 135 citations · 27 references
MedicineGeneticsOncologyEpigeneticsGene ExpressionMolecular OncologyCancer EpigeneticsCancer GenomicsDna MethylationEpigenetic Alterations In CancerEpigenetic Regulation In CancerOvarian CancerAberrant Dna MethylationCancer Dna Methylation SignaturesMalignant Ovarian NeoplasmsMalignant Ovarian TumorsOncogene HypomethylationPromoter HypermethylationRepresentative Samples
Wide-spread hypomethylation of CpG dinucleotides is characteristic of many cancers. Retrotransposons have been identified as potential targets of hypomethylation during cellular transformation. We report the results of an preliminary examination of the methylation status of CpG dinucleotides associated with the L1 and HERV-W retrotransposons in benign and malignant human ovarian tumors. We find a reduction in the methylation of CpG dinucleotides within the promoter regions of these retroelements in malignant relative to non-malignant ovarian tissues. Consistent with these results, we find that relative L1 and HERV-W expression levels are elevated in representative samples of malignant vs. non-malignant ovarian tissues.
27
Initial sequencing and analysis of the human genome
Eric S. Lander, Lauren Linton, Bruce W. Birren et al. · Nature · 2001 · 24.6K citations · Full text
Induction of Tumors in Mice by Genomic Hypomethylation
François Gaudet, John Hodgson, Amir Eden et al. · Science · 2003 · 1.5K citations
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Amir Eden, François Gaudet, Alpana Waghmare et al. · Science · 2003 · 1.4K citations
Medicine, Cancer Biology, Oncology +15
Continuous Fluorescence Monitoring of Rapid Cycle DNA Amplification
Carl T. Wittwer, Mark G. Herrmann, Alan A. Moss et al. · BioTechniques · 2013 · 1.3K citations · Full text
Continuous Fluorescence Monitoring of Rapid Cycle DNA Amplification
Carl T. Wittwer, Mark G. Herrmann, Alan A. Moss et al. · BioTechniques · 1997 · 1.1K citations · Full text